ImmunityBio Options Spot-On: On April 26th, 106.79K Contracts Were Traded, With 224.51K Open Interest

On April 26th ET, $ImmunityBio(IBRX.US)$ had active options trading, with a total trading volume of 106.79K options for the day, of which put options accounted for 19.57% of the total transactions, an

moomoo News16:30 ET

What's Going On With ImmunityBio Stock?

ImmunityBio, Inc. (NASDAQ:IBRX) shares are trading higher Friday after the company announced overall survival results in its QUILT 3.055 study.The Details:ImmunityBio said the QUILT 3.055 trial shows

Benzinga15:26 ET

Express News | ImmunityBio Shares Are Trading Higher After the Company on Thursday Announced Overall Survival Results in Its QUILT 3.055 Study

Benzinga13:57 ET

12 Health Care Stocks Moving In Friday's Intraday Session

GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.

Benzinga12:31 ET

FDA approved! ImmunityBio (IBRX.US) Potentially Major Therapy Extends OS for Patients with Refractory Cancers

ImmunityBio (IBRX.US) announced that its IL-15 superagonist anktiva (nogapendekin alfa inbakicept) obtained positive overall survival (OS) results in the QUILT 3.055 study.

Zhitong FinanceApr 25 18:52 ET

Express News | ImmunityBio Shares Are Trading Higher After the Company Announced Overall Survival Results in Its QUILT 3.055 Study

BenzingaApr 25 07:36 ET